Ad is loading...

PMCB PharmaCyte Biotech Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

PMCB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PMCB
(Try 14 days for Free)

View a ticker or compare two or three

Compare

PMCB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PMCB
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

PMCB is expected to report earnings to rise 125.00% to -9 cents per share on June 28

PharmaCyte Biotech PMCB Stock Earnings Reports

Q2'23

Est.

$-0.09

Q1'23

Beat

by $0.04

Q4'22

Missed

by $0.01

Q3'22

Est.

$-0.07

Q2'22

Missed

by $0.03

The last earnings report on March 14 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 14.51K shares outstanding, the current market capitalization sits at 12.59M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3960 Howard Hughes Parkway

Phone

+1 917 595-2850

Employees

Web

https://pharmacyte.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
CHPT	1.12	N/A	N/A
ChargePoint Holdings
WMG	32.92	-0.41	-1.23%
Warner Music Group Corp
INBS	1.48	-0.04	-2.63%
Intelligent Bio Solutions
CLPT	10.93	-0.31	-2.76%
ClearPoint Neuro
TRMD	22.85	-0.78	-3.30%
TORM plc

PMCB and Stocks

Correlation & Price change

A.I.dvisor tells us that PMCB and FATE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCB and FATE's prices will move in lockstep.

Ticker / NAME	Correlation To PMCB	1D Price Change %
PMCB	100%	-4.55%
FATE - PMCB	33% Poorly correlated	-2.88%
MBRX - PMCB	28% Poorly correlated	-12.30%
BTAI - PMCB	28% Poorly correlated	+9.20%
DTIL - PMCB	28% Poorly correlated	-1.04%
MDGL - PMCB	27% Poorly correlated	-4.66%
More